Georgetown University

Four Goulston & Storrs Attorneys Recognized as Lawdragon Green 500: 2024 Leaders in Environmental Law

Retrieved on: 
Monday, February 12, 2024

BOSTON , Feb. 12, 2024 /PRNewswire/ -- Goulston & Storrs, an Am Law 200 firm, is pleased to announce that directors Kate Heller , Jonathan Pearlson , William Seuch , and of counsel Ned Abelson have been named to the Lawdragon Green 500: 2024 Leaders in Environmental Law, which recognizes the top attorneys in the practice who "help businesses navigate environmental regulations to successfully develop projects."

Key Points: 
  • BOSTON , Feb. 12, 2024 /PRNewswire/ -- Goulston & Storrs, an Am Law 200 firm, is pleased to announce that directors Kate Heller , Jonathan Pearlson , William Seuch , and of counsel Ned Abelson have been named to the Lawdragon Green 500: 2024 Leaders in Environmental Law, which recognizes the top attorneys in the practice who "help businesses navigate environmental regulations to successfully develop projects."
  • This is the second consecutive year that all four attorneys have been selected as leaders in environmental law.
  • Her unique legal and engineering expertise makes her among the top environmental attorneys in the country.
  • Ned Abelson is a nationally recognized environmental attorney who is known for his expertise in Brownfields redevelopment, transactional work, and environmental insurance.

SSP International Announces Doubled Capacity in its Summer Science Program, Expanded Partnerships with U.S. Colleges and Increased Financial Aid

Retrieved on: 
Monday, February 12, 2024

NEW YORK, Feb. 12, 2024 /PRNewswire/ -- SSP International (SSP), a nonprofit offering advanced science immersion experiences to high school students through its Summer Science Program, today announced that this summer it will double the number of placements available to nearly 400 through new partnerships with Georgia College & State University, Georgetown University and Southeastern Oklahoma State University. These new partnerships will bring the total number of programs to 12 this summer, including five astrophysics programs, three biochemistry programs, three genomics programs and a first-of-its-kind synthetic chemistry program. To reach more deserving participants and increase access to high-quality science education for students historically underrepresented in STEM, the nonprofit will also offer $3,000 stipends to qualified participants who would otherwise have to work in the summer and, in turn, miss out on critical enrichment opportunities.  

Key Points: 
  • "Now operating as SSP International, we are excited to welcome the next generation of students interested in STEM to our Summer Science Program," said Frank Steslow, CEO.
  • "This year, we're especially focused on reaching and engaging individuals who would otherwise not have access to the Summer Science Program experience.
  • Summer Science Program provides programs in astrophysics, biochemistry and genomics taught through rigorous, collaborative research projects on college campuses.
  • If you are interested in applying for its 2024 Summer Science Program, you can visit this link for steps on how to apply: summerscience.org/admissions/how-to-apply .

Five Burns & Levinson Partners Named to 2024 Lawdragon Green 500: Leaders in Environmental Law

Retrieved on: 
Thursday, February 8, 2024

BOSTON and PROVIDENCE, R.I., Feb. 8, 2024 /PRNewswire/ -- Burns & Levinson partners Sean Coffey , Peter Durning , Thomas Mackie , David Rosenblatt , and John Shea have been selected for inclusion in the 2024 Lawdragon Green 500: Leaders in Environmental Law for their remarkable achievements in environmental law.

Key Points: 
  • BOSTON and PROVIDENCE, R.I., Feb. 8, 2024 /PRNewswire/ -- Burns & Levinson partners Sean Coffey , Peter Durning , Thomas Mackie , David Rosenblatt , and John Shea have been selected for inclusion in the 2024 Lawdragon Green 500: Leaders in Environmental Law for their remarkable achievements in environmental law.
  • He represents public companies, real estate developers, investors, small businesses, and municipalities in environmental litigation, enforcement defense, land use, and permitting.
  • He is the author of "Hazardous Waste Cleanup Law" in the Massachusetts Environmental Law treatise published by MCLE.
  • from the University of Maine Law School, his master's degree in environmental law, cum laude, from Vermont Law School, and his B.S., cum laude, from Holy Cross College.

U.S. Polo Assn. Supports Collegiate Partnership Program for Sixth Consecutive Season

Retrieved on: 
Thursday, February 8, 2024

Another contribution this year includes a 4ocean bracelet that will be given to all student-athletes, highlighting U.S. Polo Assn.

Key Points: 
  • Another contribution this year includes a 4ocean bracelet that will be given to all student-athletes, highlighting U.S. Polo Assn.
  • Sanctioned by the USPA, collegiate polo teams compete in the Fall and Spring with the official season beginning Fall 2023 and running through April 2024.
  • This season will conclude with the National Intercollegiate Championship (NIC) hosted at the Virginia Polo Center in Charlottesville, VA, from April 8-14, 2024.
  • Back for the second year, the College Polo Tour, an exchange program for collegiate polo players, continued throughout 2023 with tours to Morocco, Spain, and Argentina.

Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer

Retrieved on: 
Thursday, February 1, 2024

CHARLOTTESVILLE, Va., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today the appointment of James Doherty, Ph.D., as President and Chief Development Officer, effective February 1, 2024, reporting to Daniel O’Connell, Chief Executive Officer.

Key Points: 
  • CHARLOTTESVILLE, Va., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today the appointment of James Doherty, Ph.D., as President and Chief Development Officer, effective February 1, 2024, reporting to Daniel O’Connell, Chief Executive Officer.
  • Dr. Doherty’s responsibilities will include oversight of clinical and non-clinical development, chemistry, manufacturing & controls and regulatory functions.
  • “We are extremely excited to welcome Jim, who brings extensive experience and demonstrated leadership abilities in CNS drug development to Acumen,” Mr. O’Connell said.
  • Prior to joining Acumen, Dr. Doherty served as Chief Development Officer at Sage Therapeutics, where the team achieved U.S. Food and Drug Administration approvals of two treatments for postpartum depression.

ORISE report shows overall number of health physics degrees decreases to lowest level in decades

Retrieved on: 
Wednesday, January 31, 2024

According to the report, 21 students received bachelor’s degrees with majors in health physics in 2022 and 19 in 2021—the lowest numbers of bachelor’s degrees reported since 1973, the inception of the ORISE health physics survey.

Key Points: 
  • According to the report, 21 students received bachelor’s degrees with majors in health physics in 2022 and 19 in 2021—the lowest numbers of bachelor’s degrees reported since 1973, the inception of the ORISE health physics survey.
  • The number of health physics master’s degrees awarded in 2022 decreased by 27 percent and 25 percent from 2021 and 2019 levels, respectively.
  • The number of doctorate degrees awarded in health physics in 2022 is the second lowest number reported since 1966.
  • Oregon State University had the largest number of health physics degrees awarded in 2021 and 2022 with 6 bachelor’s degrees and 59 master’s degrees, followed by Purdue University and the Illinois Institute of Technology.

Dr. Husam Almunajed Continues Partnership With Haute Beauty Network

Retrieved on: 
Friday, February 2, 2024

NEW YORK, Feb. 2, 2024 /PRNewswire-PRWeb/ -- Dr. Husam Almunajed is a highly skilled cosmetic and restorative dentist who has made a name for himself in creating beautiful and healthy smiles for his patients. With an undergraduate degree from Villanova University and a master's degree from Georgetown University, Dr. Almunajed continued his education at the University of Connecticut School of Dental Medicine, where he completed his dental degree and a 2-year residency focused on comprehensive dental care.

Key Points: 
  • Smile Expert from New York, Dr. Husam Almunajed, continues his partnership with Haute Beauty Network, now in his sixth year.
  • "With over 20 years of experience, Dr. Almunajed founded Empire Dental Aesthetics, a state-of-the-art practice located in Manhattan, New York, specializing in cosmetic and comprehensive dentistry."
  • With over 20 years of experience, Dr. Almunajed founded Empire Dental Aesthetics, a state-of-the-art practice located in Manhattan, New York, specializing in cosmetic and comprehensive dentistry.
  • As he continues to teach and mentor the next generation of dentists, Dr. Almunajed's legacy of excellence in dentistry will undoubtedly continue to grow.

Rapidly Growing D.C. Venture Capital Firm Promotes New Partner

Retrieved on: 
Thursday, February 1, 2024

WASHINGTON, Feb. 1, 2024 /PRNewswire/ -- Strategic Cyber Ventures (SCV), a D.C. based venture capital firm that focuses on cybersecurity technology investing, announced that it is promoting one of its top investors to partner.

Key Points: 
  • WASHINGTON, Feb. 1, 2024 /PRNewswire/ -- Strategic Cyber Ventures (SCV), a D.C. based venture capital firm that focuses on cybersecurity technology investing, announced that it is promoting one of its top investors to partner.
  • Chris Ahern, a graduate of the University of Virginia and the Georgetown University MBA program, sees his promotion come as the firm accelerated its investing in the past year.
  • Joining the firm in 2017 not long after it was founded, Chris quickly became the lead investor behind several of SCV's strongest investments.
  • Thomas went on to say "Chris has grown a passion for cybersecurity that makes him a perfect fit for our firm."

Balance Point Announces Investment Team Promotions and Two New Hires Across Investment and Investor Relations Teams

Retrieved on: 
Wednesday, January 31, 2024

The firm is also pleased to announce the addition of two new associates on the investment and investor relations teams, Wills Danielsen and Nina Lorusso, respectively.

Key Points: 
  • The firm is also pleased to announce the addition of two new associates on the investment and investor relations teams, Wills Danielsen and Nina Lorusso, respectively.
  • Seth Alvord, Managing Partner said, "We are very pleased to promote Grant, Dan, and James, each of whom have added significant value to Balance Point.
  • Their expertise and dedication to our firm and portfolio companies has greatly contributed to the success of our investment platform.
  • Grant joined Balance Point in 2017 as a Senior Associate and most recently was a Senior Vice President.

Immunovia appoints Norma Alonzo Palma as new Vice President of Clinical and Medical Affairs

Retrieved on: 
Wednesday, January 31, 2024

LUND, Sweden, Jan. 31, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, today announces the appointment of Norma Alonzo Palma, PhD as Vice President of Clinical and Medical Affairs.

Key Points: 
  • LUND, Sweden, Jan. 31, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, today announces the appointment of Norma Alonzo Palma, PhD as Vice President of Clinical and Medical Affairs.
  • As announced in July 2023, Immunovia significantly restructured to focus its resources on the company's next-generation blood test for early detection of pancreatic cancer.
  • Norma most recently held the position of VP of Medical Affairs at Aadi Biosciences where she developed and executed the medical strategy and plan.
  • She will also strengthen Immunovia's partnerships with key opinion leaders, leading clinicians, and payers," says Jeff Borcherding, CEO and President of Immunovia.